当前位置:首页 - 行情中心 - 洁特生物(688026) - 财务分析 - 现金流量表

洁特生物

(688026)

  

流通市值:31.88亿  总市值:31.88亿
流通股本:1.40亿   总股本:1.40亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金465,562,540.54297,319,263.97144,608,224.04658,264,170.34
  收到的税费返还8,782,158.077,982,254.663,033,663.395,162,204.56
  收到其他与经营活动有关的现金17,881,691.0120,680,253.067,819,785.636,039,231.65
  经营活动现金流入小计492,226,389.62325,981,771.69155,461,673.03699,465,606.55
  购买商品、接受劳务支付的现金241,122,075.48167,527,582.7484,738,863.28274,107,359.17
  支付给职工以及为职工支付的现金118,359,741.7678,820,018.1533,847,849.31145,098,648.19
  支付的各项税费22,747,860.5916,209,522.6510,107,150.0446,725,633.67
  支付其他与经营活动有关的现金29,778,272.8328,320,365.175,496,647.3241,774,323.69
  经营活动现金流出小计412,007,950.66290,877,488.71134,190,509.95507,705,964.72
  经营活动产生的现金流量净额80,218,438.9635,104,282.9821,271,163.08191,759,641.83
二、投资活动产生的现金流量:
  收回投资收到的现金814,198,700612,948,800-587,287,278.37
  取得投资收益收到的现金2,592,680.41,216,544.03-2,951,247.72
  处置固定资产、无形资产和其他长期资产收回的现金净额---308,567.88
  收到的其他与投资活动有关的现金89,947,542.5120,268,247.45356,065,600426,300,057.29
  投资活动现金流入小计906,738,922.91634,433,591.48356,065,6001,016,847,151.26
  购建固定资产、无形资产和其他长期资产支付的现金43,972,460.7922,620,706.211,222,922.67124,049,648.59
  投资支付的现金810,874,200607,003,300-567,287,278.37
  取得子公司及其他营业单位支付的现金7,762,204.127,762,204.127,762,204.12-
  支付其他与投资活动有关的现金130,205,622.7320,442,446.96346,065,600374,090,656.61
  投资活动现金流出小计992,814,487.64657,828,657.28365,050,726.791,065,427,583.57
  投资活动产生的现金流量净额-86,075,564.73-23,395,065.8-8,985,126.79-48,580,432.31
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,360,0001,360,000-890,000
  其中:子公司吸收少数股东投资收到的现金1,360,0001,360,000-890,000
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计1,360,0001,360,000-890,000
  分配股利、利润或偿付利息支付的现金16,779,399.526,599,085-14,597,348.34
  其中:子公司支付给少数股东的股利、利润---150,000
  支付其他与筹资活动有关的现金32,783,422.2131,481,005.3118,808,175.441,762,079.89
  筹资活动现金流出小计49,562,821.7338,080,090.3118,808,175.4416,359,428.23
  筹资活动产生的现金流量净额-48,202,821.73-36,720,090.31-18,808,175.44-15,469,428.23
四、汇率变动对现金及现金等价物的影响-12,008,470.27-9,336,091.65-4,843,367.34-2,154,555.92
五、现金及现金等价物净增加额-66,068,417.77-34,346,964.78-11,365,506.49125,555,225.37
  加:期初现金及现金等价物余额243,950,502.75243,950,502.75243,950,502.75118,395,277.38
  期末现金及现金等价物余额177,882,084.98209,603,537.97232,584,996.26243,950,502.75
补充资料:
  净利润-22,037,218.52-49,094,610.55
  资产减值准备--14,038-26,572,760.61
  固定资产和投资性房地产折旧-27,882,397.61-52,490,733.76
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-27,882,397.61-52,490,733.76
  无形资产摊销-3,128,153.89-1,560,004.68
  处置固定资产、无形资产和其他长期资产的损失-434,950.88-801,080.79
  固定资产报废损失-165-547,737.17
  公允价值变动损失----238,219.18
  财务费用-25,560,058.3-30,406,684.34
  投资损失--1,764,774.95--2,181,291.36
  递延所得税--787,263.57--3,449,168.33
  其中:递延所得税资产减少--631,353.57--636.41
    递延所得税负债增加--155,910--3,448,531.92
  存货的减少--27,550,045.97--7,233,009.26
  经营性应收项目的减少-3,413,574.7-57,707,008.29
  经营性应付项目的增加--18,261,460.78--13,399,256.69
  债务转为资本---1,125
  不涉及现金收支的投资和筹资活动金额其他项目---1,802,568.13
  现金的期末余额-209,603,537.97-243,950,502.75
  减:现金的期初余额-243,950,502.75-118,395,277.38
  现金及现金等价物的净增加额--34,346,964.78-125,555,225.37
公告日期2026-10-312026-08-312026-04-302026-04-30
审计意见(境内)标准无保留意见
TOP↑